BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

313 related articles for article (PubMed ID: 24512624)

  • 21. Inducible formation of leader cells driven by CD44 switching gives rise to collective invasion and metastases in luminal breast carcinomas.
    Yang C; Cao M; Liu Y; He Y; Du Y; Zhang G; Gao F
    Oncogene; 2019 Nov; 38(46):7113-7132. PubMed ID: 31417182
    [TBL] [Abstract][Full Text] [Related]  

  • 22. CD44 targets Na(+)/H(+) exchanger 1 to mediate MDA-MB-231 cells' metastasis via the regulation of ERK1/2.
    Chang G; Wang J; Zhang H; Zhang Y; Wang C; Xu H; Zhang H; Lin Y; Ma L; Li Q; Pang T
    Br J Cancer; 2014 Feb; 110(4):916-27. PubMed ID: 24434427
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Lipid rafts and caveolin-1 are required for invadopodia formation and extracellular matrix degradation by human breast cancer cells.
    Yamaguchi H; Takeo Y; Yoshida S; Kouchi Z; Nakamura Y; Fukami K
    Cancer Res; 2009 Nov; 69(22):8594-602. PubMed ID: 19887621
    [TBL] [Abstract][Full Text] [Related]  

  • 24. PTTG1 oncogene promotes tumor malignancy via epithelial to mesenchymal transition and expansion of cancer stem cell population.
    Yoon CH; Kim MJ; Lee H; Kim RK; Lim EJ; Yoo KC; Lee GH; Cui YH; Oh YS; Gye MC; Lee YY; Park IC; An S; Hwang SG; Park MJ; Suh Y; Lee SJ
    J Biol Chem; 2012 Jun; 287(23):19516-27. PubMed ID: 22511756
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Simvastatin prevents skeletal metastasis of breast cancer by an antagonistic interplay between p53 and CD44.
    Mandal CC; Ghosh-Choudhury N; Yoneda T; Choudhury GG; Ghosh-Choudhury N
    J Biol Chem; 2011 Apr; 286(13):11314-27. PubMed ID: 21199873
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Lipid raft-mediated miR-3908 inhibition of migration of breast cancer cell line MCF-7 by regulating the interactions between AdipoR1 and Flotillin-1.
    Li Y; Shan F; Chen J
    World J Surg Oncol; 2017 Mar; 15(1):69. PubMed ID: 28327197
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Molecular mechanism of CD44 homodimerization modulated by palmitoylation and membrane environments.
    Ma Z; Shi S; Ren M; Pang C; Zhan Y; An H; Sun F
    Biophys J; 2022 Jul; 121(14):2671-2683. PubMed ID: 35733341
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Palmitoylated claudin7 captured in glycolipid-enriched membrane microdomains promotes metastasis via associated transmembrane and cytosolic molecules.
    Thuma F; Heiler S; Schnölzer M; Zöller M
    Oncotarget; 2016 May; 7(21):30659-77. PubMed ID: 27120791
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Stromal hyaluronan interaction with epithelial CD44 variants promotes prostate cancer invasiveness by augmenting expression and function of hepatocyte growth factor and androgen receptor.
    Ghatak S; Hascall VC; Markwald RR; Misra S
    J Biol Chem; 2010 Jun; 285(26):19821-32. PubMed ID: 20200161
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of hyaluronan on the invasive properties of human breast cancer cells in vitro.
    Herrera-Gayol A; Jothy S
    Int J Exp Pathol; 2001 Jun; 82(3):193-200. PubMed ID: 11488992
    [TBL] [Abstract][Full Text] [Related]  

  • 31. 4-cholesten-3-one decreases breast cancer cell viability and alters membrane raft-localized EGFR expression by reducing lipogenesis and enhancing LXR-dependent cholesterol transporters.
    Elia J; Carbonnelle D; Logé C; Ory L; Huvelin JM; Tannoury M; Diab-Assaf M; Petit K; Nazih H
    Lipids Health Dis; 2019 Sep; 18(1):168. PubMed ID: 31477154
    [TBL] [Abstract][Full Text] [Related]  

  • 32. CD44 variant isoforms expressed by breast cancer cells are functional E-selectin ligands under flow conditions.
    Shirure VS; Liu T; Delgadillo LF; Cuckler CM; Tees DF; Benencia F; Goetz DJ; Burdick MM
    Am J Physiol Cell Physiol; 2015 Jan; 308(1):C68-78. PubMed ID: 25339657
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Proteome scale characterization of human S-acylated proteins in lipid raft-enriched and non-raft membranes.
    Yang W; Di Vizio D; Kirchner M; Steen H; Freeman MR
    Mol Cell Proteomics; 2010 Jan; 9(1):54-70. PubMed ID: 19801377
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The hyaluronan receptors CD44 and Rhamm (CD168) form complexes with ERK1,2 that sustain high basal motility in breast cancer cells.
    Hamilton SR; Fard SF; Paiwand FF; Tolg C; Veiseh M; Wang C; McCarthy JB; Bissell MJ; Koropatnick J; Turley EA
    J Biol Chem; 2007 Jun; 282(22):16667-80. PubMed ID: 17392272
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Palmitoylation targets AKAP79 protein to lipid rafts and promotes its regulation of calcium-sensitive adenylyl cyclase type 8.
    Delint-Ramirez I; Willoughby D; Hammond GR; Ayling LJ; Cooper DM
    J Biol Chem; 2011 Sep; 286(38):32962-75. PubMed ID: 21771783
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cancer-Associated MORC2-Mutant M276I Regulates an hnRNPM-Mediated CD44 Splicing Switch to Promote Invasion and Metastasis in Triple-Negative Breast Cancer.
    Zhang FL; Cao JL; Xie HY; Sun R; Yang LF; Shao ZM; Li DQ
    Cancer Res; 2018 Oct; 78(20):5780-5792. PubMed ID: 30093560
    [TBL] [Abstract][Full Text] [Related]  

  • 37. R7-binding protein targets the G protein beta 5/R7-regulator of G protein signaling complex to lipid rafts in neuronal cells and brain.
    Nini L; Waheed AA; Panicker LM; Czapiga M; Zhang JH; Simonds WF
    BMC Biochem; 2007 Sep; 8():18. PubMed ID: 17880698
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Proteoglycan serglycin promotes non-small cell lung cancer cell migration through the interaction of its glycosaminoglycans with CD44.
    Guo JY; Chiu CH; Wang MJ; Li FA; Chen JY
    J Biomed Sci; 2020 Jan; 27(1):2. PubMed ID: 31898491
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Chemotaxis towards hyaluronan is dependent on CD44 expression and modulated by cell type variation in CD44-hyaluronan binding.
    Tzircotis G; Thorne RF; Isacke CM
    J Cell Sci; 2005 Nov; 118(Pt 21):5119-28. PubMed ID: 16234326
    [TBL] [Abstract][Full Text] [Related]  

  • 40. CD44/CD24 as potential prognostic markers in node-positive invasive ductal breast cancer patients treated with adjuvant chemotherapy.
    Adamczyk A; Niemiec JA; Ambicka A; Mucha-Małecka A; Mituś J; Ryś J
    J Mol Histol; 2014 Feb; 45(1):35-45. PubMed ID: 23835592
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.